FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:2093-2095 June 27, 2002 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Steinbrook, R. PubMed Citation

To the Editor: The Health Policy Report by Steinbrook on the crisis at Johns Hopkins (Feb. 28 issue)¹ skirts the key issues. There were 2600 protocols that required re-review as part of the corrective plan, as indicated in the article, but there is no indication of the total number of studies that were stopped when the Food and Drug Administration (FDA) intervened. Clearly, more research was affected. It was noted that the institutional review board (IRB) was criticized because it had to consider 800 new protocols — presumably its workload for a year — in addition to its annual reviews. . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.